Weight Loss Guide, The Care Pharmacy
A clear, UK-specific breakdown of what LillyDirect actually is, how it differs from the American version, and the safe, regulated way to access Mounjaro for weight management.
A lot of the traffic around “LillyDirect” comes from people trying to work out whether they can pay for tirzepatide themselves, outside the NHS, in the same way American patients seem to through the US self-pay portal. It is a fair question, but the UK answer is not a simple yes. There is no manufacturer-run checkout here where you can pay Lilly directly for Mounjaro. If you want to fund your own treatment privately, you still have to go through a regulated prescriber first, and the self-pay journey looks quite different from what the US version of LillyDirect suggests. This guide separates the two models properly, explains where self-pay genuinely fits into the UK picture, and sets out how to fund Mounjaro (tirzepatide) privately without putting yourself at risk.
Whether you are just starting to research your options or you are ready to begin treatment, our pharmacist-led team can talk you through what is realistic for your circumstances. You can get in touch with us with any questions, or start an online consultation to check your eligibility for weight management treatment.
Self-pay in the UK, at a glance
On this page
Quick Answer
LillyDirect is a patient-facing platform created by Eli Lilly and Company, the manufacturer behind tirzepatide (branded Mounjaro in the UK) and dulaglutide (Trulicity). In the United States, the platform links patients with independent telehealth providers and connected pharmacies, and it advertises certain Lilly medicines on a self-pay basis. Even there, Lilly itself does not make clinical decisions or hand medicines directly to patients; it facilitates the connection between prescriber, pharmacy and patient.
For a long time, LillyDirect simply did not exist as a service in the UK. That changed from around 25 June 2026, when a UK version launched, built to fit UK medicines law rather than copying the American structure. Because manufacturers in the UK are not permitted to sell prescription-only medicines straight to the public, LillyDirect UK operates purely as a dispensing and delivery arm. A UK-regulated prescriber has to issue a private prescription first, after which Lilly’s UK dispensing partners fulfil and post the medicine to the patient. There is no direct “buy now” self-pay function running through Lilly in this country.
This distinction is not just technical. Some UK patients, having read about the American service, go looking for an equivalent direct-purchase route and either get confused about what is on offer or, worse, stumble across websites impersonating LillyDirect to sell counterfeit or unlicensed products. Sourcing weight loss injections outside properly regulated channels carries a genuine risk of receiving falsified or incorrectly dosed medicines.
Because the two versions share a name but operate very differently, it is worth setting the distinctions out clearly.
Because Mounjaro is a prescription-only medicine in the UK, the process always begins with a clinical assessment, not a purchase. Whether you use LillyDirect’s dispensing partners or any other GPhC-registered pharmacy, the sequence is broadly the same:
You can verify that a pharmacy is properly registered using the GPhC online register for Great Britain, or the Pharmaceutical Society of Northern Ireland register if you are based in Northern Ireland. Clinical providers themselves are inspected by the Care Quality Commission in England, Healthcare Improvement Scotland, Healthcare Inspectorate Wales, or the Regulation and Quality Improvement Authority in Northern Ireland, so it is worth checking a provider’s registration with the relevant body before booking a consultation.
Self-pay simply means funding your own treatment rather than relying on NHS provision, and it remains open to anyone whether or not they would qualify for NHS-funded Mounjaro. Patients who do not meet NHS funding criteria, or who would simply rather pay privately, can still access Mounjaro, but only through a licensed prescriber and a registered pharmacy. Mounjaro is the sole UK brand of tirzepatide and holds MHRA authorisation for both type 2 diabetes and long-term weight management, so the same product is used regardless of which of those two reasons brings you to treatment. Your prescriber will confirm which dose and indication fits your situation.
Self-pay costs generally fall into three categories, and they vary between providers, so always ask for a full, itemised breakdown before committing:
Be wary of unusually cheap offers with no consultation attached; a low headline price is often a sign that proper clinical oversight is missing.
Eligibility for private prescribing is a separate question from NHS funding, and the two use different thresholds:
Certain groups should not use tirzepatide, or need particular care before starting: pregnant or breastfeeding women should avoid it altogether and use effective contraception if of childbearing potential; anyone with a history of pancreatitis or significant gastrointestinal disease needs careful assessment first. One notable UK-specific point is that a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, which is a contraindication on the US label, is not listed as a contraindication or specific warning in the UK and EU SmPC, where hypersensitivity remains the only formal contraindication. Even so, anyone with thyroid concerns should raise them with their prescriber before starting.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for making sure medicines sold in the UK, whether on the NHS or privately, are safe, effective and of an acceptable standard. Every medicine legally supplied here needs a valid UK marketing authorisation or a recognised exemption. Mounjaro has full MHRA authorisation following formal clinical evaluation. Zepbound, by contrast, is authorised in the US only and has no UK licence, which is exactly why it should never be sourced or imported here.
One of the biggest risks in this space is the rise of unregulated online sellers offering injectable weight loss medicines with no valid prescription at all. The MHRA has issued safety alerts about counterfeit and falsified weight loss injections circulating in the UK, some containing the wrong dose, unlicensed ingredients, or no active ingredient whatsoever. Buying from unverified sources risks both treatment failure and serious harm.
Based on the UK SmPC, tirzepatide’s side effect profile includes:
Other precautions worth knowing about include an increased risk of hypoglycaemia when tirzepatide is combined with insulin or a sulfonylurea, a possible short-term worsening of diabetic retinopathy if blood glucose improves rapidly, and a risk of dehydration or acute kidney injury if vomiting or diarrhoea become persistent. As already noted, it should not be used in pregnancy or while breastfeeding, and anyone planning a pregnancy should discuss stopping treatment with their prescriber in advance.
Contact your prescriber or GP promptly if you experience severe or ongoing abdominal pain, persistent vomiting, signs of dehydration, or symptoms of an allergic reaction. Anyone, patient or healthcare professional, can report a suspected side effect through the MHRA Yellow Card Scheme, which feeds into ongoing safety monitoring once a medicine is on the market. Sticking to a regulated provider means any adverse events you experience are properly recorded and followed up.
No. UK law does not allow a manufacturer to sell prescription-only medicines straight to patients. LillyDirect UK only dispenses and delivers Mounjaro once a UK-registered prescriber has issued a private prescription elsewhere in the process.
Foundayo is the brand name for orforglipron, a GLP-1 receptor agonist authorised by the MHRA on 10 August 2026, making the UK the first country in Europe to approve it. The key practical difference is the form it comes in: Foundayo is a tablet taken by mouth, whereas Mounjaro is given by injection. Both work by acting on appetite-regulating pathways in the brain, helping people feel fuller for longer and reducing food cravings, and both can improve blood sugar control in people with type 2 diabetes. Foundayo is authorised for weight management and weight maintenance in adults with a BMI of 30 or above, or a BMI of 27 to 30 with at least one weight-related health condition, alongside a reduced-calorie diet and increased activity, as well as for improving glycaemic control in people whose type 2 diabetes is not well managed on their current treatment.
Treatment starts at a low dose of 0.8 mg and is gradually increased in stages, moving through 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and up to 17.2 mg, with at least a month spent at each dose before stepping up. This gradual approach is designed to let the body adjust and to reduce the likelihood of side effects. As with any prescribed medicine, patients should follow the specific instructions in the Patient Information Leaflet supplied with their prescription rather than relying on a general dosing outline.
The same principle applies as with Mounjaro: MHRA authorisation means the medicine can legally be prescribed in the UK, but it does not create a direct-purchase route from the manufacturer. Anyone wanting to fund treatment with Foundayo privately will still need an assessment from a UK-registered prescriber, who will confirm suitability against the licensed criteria before issuing a prescription, followed by dispensing through a GPhC-registered pharmacy. Exact self-pay pricing and availability through individual clinics and pharmacies is expected to become clearer as providers roll the medicine out, so always check directly with your chosen provider.
NHS funding is governed by NICE technology appraisal TA1026, which sets a BMI threshold of 35 kg/m² or above with a related health condition, reflecting how NHS resources are allocated. Private prescribing instead follows the medicine’s own licence (SmPC), which for tirzepatide permits treatment from a BMI of 27 kg/m² with a related condition, or 30 kg/m² on its own. The two thresholds exist for different reasons and are not interchangeable.
Check the pharmacy against the GPhC online register, or the PSNI register if you are in Northern Ireland, and check that any clinical provider is registered with the CQC, HIS, HIW or RQIA depending on where they operate. Genuine providers will always require a consultation before prescribing, rather than offering medicines on request.
Stop using it, keep the packaging and any remaining product, and report it through the MHRA Yellow Card Scheme. If you have experienced a reaction, seek medical advice promptly and mention what you suspect about the product’s origin.
Not automatically. Pricing is set by the prescribing service and the dispensing pharmacy rather than by Lilly, so costs can still vary between LillyDirect’s partners and other GPhC-registered pharmacies. Always ask for a clear breakdown of consultation, prescription and delivery costs before proceeding.
LillyDirect’s arrival in the UK is a genuinely useful addition to how Mounjaro can be dispensed and delivered, but it is not the direct-to-consumer shortcut that some patients expect after seeing the American version. The safeguards built into the UK model, a mandatory prescription, GPhC-registered dispensing, and MHRA oversight, exist to protect patients from exactly the kind of counterfeit and unregulated products that have been flagged as a growing problem.
If you are weighing up your options for medically supported weight loss, the safest route is always the same: a proper clinical consultation, a prescription only where appropriate, and dispensing through a pharmacy you can verify. Our pharmacist-led team can help you understand whether you meet the criteria for treatment and what a realistic, transparent cost looks like.
Get in touch with us if you have questions about accessing Mounjaro safely, or complete our online consultation to find out if weight management treatment is right for you.
Ready to find out what is right for you?
Start a free, confidential online consultation with our pharmacist-led team. Mounjaro and other prescription weight loss treatments are available following clinical assessment.
This article was clinically reviewed by our Superintendent Pharmacist, who is registered with the General Pharmaceutical Council and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: September 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Weight Loss Guide, The Care Pharmacy Can Weight Loss Injections Help During Menopause? Menopause changes how and where your body stores weight. Here is how GLP-1 medicines fit into that picture, who tends to be eligible, and how the main options compare. Explore Weight Loss Treatment Weight gain during perimenopause and menopause is […]
Weight Loss Guide, The Care Pharmacy Weight Loss London: Comparing Every Route Before You Choose An honest comparison of the NHS, private in-clinic, and online pharmacy routes to medically supported weight loss in London, including which treatments are available and who qualifies. Explore Weight Loss Treatment at The Care Pharmacy If you are based in […]
Orlistat on the NHS is available — but navigating the eligibility criteria, waiting times, and ongoing prescribing conditions that come with NHS access is a process that leaves many patients either ineligible, frustrated, or waiting far longer than they would like. Understanding exactly what the NHS will and will not provide, and under what conditions, […]
Patient reviews of Orlistat paint a picture that is more nuanced than most weight loss medication discussions acknowledge — some patients find it highly effective and straightforward to use, while others find the gastrointestinal side effects a significant barrier to long-term adherence. Understanding what drives these very different experiences, and whether Orlistat is likely to […]
June 2026 · The Care Pharmacy · Clinically reviewed by Mohammed Ismail Lakhi MPharm, Superintendent Pharmacist The question coming up more and more: is there a pill version of Mounjaro or Wegovy? The short answer is – the Wegovy pill is available now in the UK. The landscape has moved fast, and understanding what’s available […]
Thinking of switching your weight loss treatment to The Care Pharmacy? Moving providers doesn’t mean restarting. This guide covers how switching works, what happens to your dose, what to bring, First Dose Video Supervision, transparent pricing for Mounjaro, Wegovy and Saxenda, and how to compare providers safely before you make the move.
